Non categorizzato Pfizer down 4% on call to scrap weight-loss pill trial Dicembre 1, 2023 0 commenti Shares of Pfizer Inc. tumbled during the premarket trade on Friday after the pharmaceutical giant announced it will stop developing the twice-daily version of its experimental weight loss pill due to … About the author:
Get involved!
Comments